HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
A Shahsafaei Selected Research
A Shahsafaei Research Topics
Disease
3
Neoplasms (Cancer)
07/2000 - 01/2000
1
Chronic Renal Insufficiency
02/2001
1
Segmental glomerulosclerosis
10/2000
1
Glandular and Epithelial Neoplasms (Neoplasms, Glandular)
09/2000
1
Thymoma (Thymic Carcinoma)
09/2000
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2000
1
T-Cell Lymphoma (Lymphoma, T Cell)
07/2000
1
Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
07/2000
1
Squamous Cell Carcinoma (Epidermoid Carcinoma)
06/2000
1
Adenocarcinoma
03/2000
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2000
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2000
Drug/Important Bio-Agent (IBA)
2
Ligands
IBA
07/2000 - 01/2000
2
Chemokine Receptors
IBA
07/2000 - 01/2000
1
candesartan
IBA
02/2001
1
Enalapril
FDA Link
Generic
02/2001
1
N 30
IBA
02/2001
1
Proteins (Proteins, Gene)
FDA Link
10/2000
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2000
1
Cytokines
IBA
10/2000
1
Histocompatibility Antigens Class II
IBA
09/2000
1
invariant chain (Ii-Key)
IBA
09/2000
1
Paraffin
IBA
09/2000
1
Anaplastic Lymphoma Kinase
IBA
07/2000
1
Monoclonal Antibodies
IBA
07/2000
1
Chemokines
IBA
07/2000
1
CCR4 Receptors
IBA
07/2000
1
Cyclin D1
IBA
06/2000
1
Eicosapentaenoic Acid
IBA
06/2000
1
Omega-3 Fatty Acids (Omega 3 Fatty Acids)
IBA
06/2000
Therapy/Procedure
1
Nephrectomy
02/2001
1
Oral Administration
06/2000
1
Chemoradiotherapy
03/2000